Foresight Diagnostics
Foresight Diagnostics is a molecular diagnostics company focused on advancing non-invasive cancer detection through innovative liquid biopsy technologies. The company integrates molecular biology, bioinformatics, and next-generation sequencing to develop clinically impactful solutions. They offer a collaborative environment where scientific innovation and quality are prioritized, allowing team members to contribute to meaningful projects and grow professionally.
Headquarters
Boulder, Colorado, United States
Company Size
51-200 employees
Founded
2020
Foresight Diagnostics is a biotechnology company focused on advancing cancer diagnostics through innovative technology. Specializing in precision genomics and bioinformatics, Foresight develops tests like Foresight CLARITY™, which utilizes advanced methods to detect minimal residual disease and improve patient outcomes. Collaborating with biopharma and academic researchers, Foresight is committed to enhancing clinical decision-making and drug development in oncology.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Foresight Diagnostics.
Natera Acquires Foresight Diagnostics
Dec 5, 2025
Research Assistant Entry - Lab of Dr. Wang and Dr. Yang
Thomas Jefferson University
Post-Doctoral Research Fellow in Cancer Genomics, Precision Oncology, and Liquid Biopsy
Thomas Jefferson University
Pathologist (Advanced Diagnostics)
William Osler Health System
2026 Summer Intern - Sequencing Workflows and Applications
Roche
Sr. Bioinformatics Scientist
Abbott Laboratories
Oncology Account Executive
BillionToOne